BeOne Medicines Ltd.

NASDAQ: ONC · Real-Time Price · USD
321.57
11.88 (3.84%)
At close: Aug 15, 2025, 3:59 PM
321.00
-0.18%
After-hours: Aug 15, 2025, 07:27 PM EDT

BeOne Medicines Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
94.32M 1.27M -151.88M -121.35M -120.41M -251.15M -367.55M 215.41M -381.14M -348.43M -445.33M -552.76M -571.45M -434.27M -585.65M -413.86M -480.34M 66.5M
Depreciation & Amortization
35.61M 32.8M 50.25M 71.29M 24.93M 25.29M 23.82M 21.51M 22.34M 20.01M 18.02M 16.2M 15.46M 16.6M 13.12M 12.18M 11.53M 9.63M
Stock-Based Compensation
150.81M 95.48M 107.62M 114.7M 130.64M 88.71M 92.78M 96.12M 103.33M 75.39M 78.13M 78.18M 81.31M 65.56M 63.01M 67.08M 64.79M 45.83M
Other Working Capital
48.95M -18.58M 78.26M 125.13M 23.25M -84.37M 160.27M -111.84M 10.76M -121.96M -29.98M -53.69M 105.37M -132.38M 401.78M -30.33M -39.19M 105.74M
Other Non-Cash Items
-22.5M -7.44M 88.04M -6.74M -17.34M -16.07M 12.2M -353.67M -3.07M -16.65M 29.52M -10.52M -14.39M -1.3M 15.69M -45.64M 26.68M -9.84M
Deferred Income Tax
n/a n/a n/a n/a n/a n/a -46K 750K -51K 36K 1.68M -7.17M 12.84M -5.29M -2.68M -26.1M -60K -12.25M
Change in Working Capital
5.35M -78.03M -18.86M 130.47M -113.41M -155.36M 17.02M -58.16M -35.34M -294.06M -197K -85.84M 96.28M 122.14M -11.33M -89.38M -42.87M 25.23M
Operating Cash Flow
263.6M 44.08M 75.16M 188.37M -95.59M -308.57M -221.64M -78.15M -293.89M -563.78M -318.19M -561.91M -379.96M -236.56M -507.84M -495.71M -420.27M 125.09M
Capital Expenditures
-63.83M -116.41M -92.48M -133.66M -109.95M -193.05M -166.91M -182.29M -121.47M -125.58M -170.02M -128.66M -50.29M -120.13M -158.39M -67.04M -38.53M -50.89M
Cash Acquisitions
n/a n/a n/a n/a n/a n/a 9.95M 24.41M n/a n/a -159.89M -278.14M -709M n/a -43.41M n/a n/a 8.5M
Purchase of Investments
n/a n/a n/a n/a n/a n/a -1.39M -4M -10.52M -1.06M -2.66M -3.23M -11M -504K -128.5M -705.83M -592.89M -764.16M
Sales Maturities Of Investments
n/a 1.8M n/a n/a n/a 2.65M 105.72M 19K 190.54M 376.96M 211.22M 301.37M 720M 331.03M 388.5M 760.88M 890.51M 1.11B
Other Investing Acitivies
-22.78M -67.33M -1.13M -227K -1.08M -19.43M -9.95M -24.41M 9.25M -9.25M 159.89M 278.14M 709M n/a 50.91M n/a -7.5M -8.5M
Investing Cash Flow
-66.61M -121.94M -93.61M -133.88M -111.03M -209.83M -62.58M -186.28M 67.8M 241.06M 38.54M 169.48M 658.71M 210.39M 109.11M -11.99M 251.6M 291.95M
Debt Repayment
26.08M -97.14M -13.32M -3.56M 14.45M 147.5M 343.69M -93.97M 162.5M -51.46M -121.65M 103.54M -24.67M -23.15M -18.53M 12.62M 25.78M 81.67M
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
8.95M 63.36M 8.79M 16.22M 8.56M 14.79M 3.36M 17.18M 3.58M 31.59M 11.29M 16.7M 7.09M 11.88M 10.57M 46.59M 9.85M 25.75M
Financial Cash Flow
35.02M -33.78M -4.52M 12.66M 23.02M 162.29M 347.05M -76.78M 166.08M -19.87M -110.37M 120.24M -17.58M -11.27M 3.38B 109.21M 35.63M 107.42M
Net Cash Flow
255.5M -108.16M -74.68M 95.5M -189.5M -378.55M 105.09M -340.68M -122.19M -331.27M -325.48M -334.9M 180.96M -28.44M 2.99B -396.99M -123.72M 520.4M
Free Cash Flow
199.77M -72.33M -17.32M 54.71M -205.54M -501.62M -388.55M -260.44M -415.36M -689.36M -488.21M -690.56M -430.25M -356.69M -666.23M -562.76M -458.8M 74.21M